Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2007
05/29/2007US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation
05/29/2007US7223790 Dimeric compounds and their use as anti-viral agents
05/29/2007US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex
05/29/2007US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets
05/29/2007US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
05/29/2007US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies
05/29/2007US7223762 Bind to Very Late Antigen-4 (VLA-4); treating asthma; 3-(5-(2-Methylphenyl)-2-(N-cyclohexyl-N-methylamino)pyrimidin-4-ylamino)-3-(4-(dimethylaminocarbonyl)oxyphenyl)propanoic Acid for example
05/29/2007US7223760 Substituted triazole compounds
05/29/2007US7223748 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
05/29/2007US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1
05/29/2007US7223394 Human antibodies that bind human TNFα
05/29/2007CA2251297C Oral preparations comprising s-(3-hydroxypropyl)-l-cysteine
05/29/2007CA2214565C New cryptophycins from synthesis
05/24/2007WO2007059515A2 Compositions of lipoxygenase inhibitors
05/24/2007WO2007059021A1 Soft anticholinergic zwitterions
05/24/2007WO2007058322A1 Basic group-containing compound and use thereof
05/24/2007WO2007057714A2 Pharmaceutical compositions comprising methotrexate
05/24/2007WO2007057705A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr)
05/24/2007WO2007057223A1 Organic compounds comprising a glycopyrronium salt
05/24/2007WO2007057222A1 Organic compounds comprising a glycopyrrolium salt
05/24/2007WO2007057221A2 Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
05/24/2007WO2007057219A1 Treatment of asthma and copd using triple-combination therapy
05/24/2007WO2007020479A3 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion
05/24/2007WO2004034973A3 Method of treating snoring and other obstructive breathing disorders
05/24/2007US20070117843 Quinoline inhibitors of cGMP phosphodiesterase
05/24/2007US20070117842 Polymorph of 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6- quinolinecarboxamide and a process for the preparation of the same
05/24/2007US20070117788 Combination of a dopamine D2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways and other inflammatory diseases
05/24/2007US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof
05/24/2007US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
05/24/2007US20070116688 Methods of organ regeneration
05/24/2007CA2630224A1 Organic compounds comprising a glycopyrrolium salt
05/24/2007CA2629437A1 Pharmaceutical compositions comprising methotrexate
05/24/2007CA2628630A1 Compositions of lipoxygenase inhibitors
05/24/2007CA2628321A1 Treatment of asthma and copd using triple-combination therapy
05/24/2007CA2628172A1 Organic compounds comprising a glycopyrronium salt
05/24/2007CA2628170A1 Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
05/24/2007CA2627982A1 Soft anticholinergic esters
05/24/2007CA2627790A1 Compositions useful for prevention and treatment of common cold and influenza-like symptoms
05/24/2007CA2626122A1 Compositions comprising lipoxygenase inhibitors and cyclodextrin
05/23/2007EP1786800A2 Substituted biaryl piperazinyl-pyridine analogues
05/23/2007EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists
05/23/2007EP1786436A2 Method for improving ventilatory efficiency
05/23/2007EP1786426A1 Soluble amide & ester pyrazinoylguanidine sodium channel blockers
05/23/2007EP1786410A2 The treatment of inflammatory disorders and pain
05/23/2007EP1651641B1 Nicotinamide derivatives useful as pde4 inhibitors
05/23/2007EP1625127B1 Azaindole compounds as kinase inhibitors
05/23/2007EP1237845B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
05/23/2007EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
05/23/2007CN1968709A VEGF inhibitors for the treatment of malignant pleural effusion
05/23/2007CN1966517A Earthworm protein EP-2 and its separation method and uses
05/23/2007CN1966056A Medicament for treating bronchial asthma
05/23/2007CN1966055A Medicament for treating chronic bronchitis and preparation method thereof
05/23/2007CN1966013A Drink for relieving cough
05/23/2007CN1966011A Medicament for clearing heat, resolving phlegm and caring liver used for infant
05/23/2007CN1966010A Medicament for opening orifices and tranquilizing mind for treating wind syndrome caused by excessive heat of infant
05/23/2007CN1966009A Medicament for treating avian nephropathogenic infectious bronchitis
05/23/2007CN1966000A Chinese medicinal formulation for treating pulmonary tuberculosis
05/23/2007CN1965999A Drink capable of clearing throat
05/23/2007CN1965993A Natural botanical extraction liquid for preventing and treating livestock and birds respiratory disease and preparation process thereof
05/23/2007CN1965985A Orally administered Chinese medicinal mixture for treating infant allergic rhinitis and preparation process thereof
05/23/2007CN1965983A Medicament for treating tonsillitis, preparation process and using method thereof
05/23/2007CN1965960A Medicinal decoction for treating acute tonsillitis and method for preparing same
05/23/2007CN1965932A Pear extractive cold-pressing hypothermia preparation method and use thereof in preparation of 'Chuan Bei Xue Li' extract
05/23/2007CN1965900A Externally applied Chinese medicinal composition for treating nasal sinuitis
05/23/2007CN1965893A Liquid formulation for treating allergic rhinitis
05/23/2007CN1965892A Liquid formulation for treating allergic rhinitis
05/23/2007CN1965880A Ointment for treating tonsillitis
05/23/2007CN1965879A Chinese medicinal effective parts for treating nasal inflammation and preparation process thereof
05/23/2007CN1965876A Compound Chinese medicinal formulation for treating laryngopharyngitis and preparation process thereof
05/23/2007CN1965874A Preparation of total aglycone of india pokeberry and application thereof in cough-relieving sputum-resolving medicament
05/23/2007CN1965851A Composition prepared by ambroxol and four kinds of antibacterials respectively
05/23/2007CN1965833A 3CL protease inhibitor of non-peptide SARS coronavirus and use thereof
05/23/2007CN1317002C Chinese traditional medicine preparation for treating laryngopharyngitis
05/23/2007CN1316999C Medicine for treating wind warmth and lung heat pathocondition and its preparation method
05/23/2007CN1316964C Cough asthma stoppig drip pill and its preparation method
05/23/2007CN1316961C Grosvenor's momordica fruit drip pill an its preparation method
05/22/2007US7220867 Dissolving with crystal growth inihibitos; drying
05/22/2007US7220862 Calcitonin gene related peptide receptor antagonists
05/22/2007US7220834 FHIT proteins and nucleic acids and methods based thereon
05/22/2007US7220829 Cytokine binding domain of cytokine receptors
05/22/2007US7220771 Jun n-terminal kinase inhibitors
05/22/2007US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties
05/22/2007US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example
05/22/2007US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders
05/22/2007US7220746 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis
05/22/2007US7220742 For therapy of respiratory complaints
05/22/2007US7220739 Therapeutic application of pro-apoptotic benzodiazepines
05/22/2007US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion
05/22/2007US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening
05/22/2007US7220403 Pharmaceutical formulation of fluticasone propionate
05/22/2007CA2276694C New fatty acid derivatives
05/22/2007CA2242562C Human dnase resistant to actin inhibition
05/18/2007WO2007056593A2 α-HELIX MIMETICS AND METHOD RELATING TO THE TREATMENT OF CANCER STEM CELLS
05/18/2007WO2007056513A1 α-HELIX MIMETICS AND METHODS RELATING TO THE TREATMENT OF FIBROTIC DISORDERS
05/18/2007WO2007056341A1 Heterocyclic modulators of atp-binding cassette transporters
05/18/2007WO2007056195A2 Surfactant protein-d for prevention and treatment of lung infections and sepsis
05/18/2007WO2007055599A1 Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof
05/18/2007WO2007055183A1 Benzene derivative or salt thereof
05/18/2007WO2007054498A1 Aerosolformulation for inhalation
05/18/2007WO2007054216A1 Diaryl urea for treating pulmonary hypertension